GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Investments And Advances

TrivarX (TrivarX) Investments And Advances : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX Investments And Advances?

TrivarX's Investments And Advances for the quarter that ended in Dec. 2023 was $0.00 Mil.


TrivarX Investments And Advances Historical Data

The historical data trend for TrivarX's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Investments And Advances Chart

TrivarX Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

TrivarX Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TrivarX Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


TrivarX (TrivarX) Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd Formerly Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development, and early-stage commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing monitoring, and management of depression and other mental health conditions. It serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets; Australia and the United States. The company has one operating segment, being the research, development, and commercialization of its Software as a Service product.

TrivarX (TrivarX) Headlines

From GuruFocus

Medibio Granted CE Mark Approval for MEBsleep

By PRNewswire PRNewswire 01-19-2021

Medibio Receives CE Certification

By Marketwired Marketwired 05-03-2018

Peer-reviewed Neurology Publication on Medibio Science

By Marketwired Marketwired 06-27-2018

Medibio Provides Updated Company Presentation

By Marketwired Marketwired 10-05-2018

Medibio Named Finalist for Prestigious Optus My Business Award

By Marketwired Marketwired 10-01-2018

Medibio Launches Global Corporate Mental Health Product

By Marketwired Marketwired 05-01-2018